+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

Single-cell Sequencing Services and Technologies Market, 2020-2030 - Product Thumbnail Image

Single-cell Sequencing Services and Technologies Market, 2020-2030

  • Report
  • September 2020
  • 220 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
Mobile Apps for DNA Sequencing: Global Markets - Product Thumbnail Image

Mobile Apps for DNA Sequencing: Global Markets

  • Report
  • February 2018
  • 192 Pages
  • Global
From
From
From
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more